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A B S T R A C T
A real-time PCR assay with a Taqman probe was
developed that targeted the polA gene of Trepo-
nema pallidum. The test was validated using an
analytical panel (n = 140) and a clinical panel of
genital samples (n = 112) from patients attending
a sexually transmitted infections clinic. High
sensitivities and specificities of 94–100% were
achieved using two real-time PCR platforms, the
Rotor-Gene and the iCycler. The assay can be
completed within 2 h, enabling reporting in <8 h.
This fast and robust assay is suitable for im-
plementation in routine laboratories for diagnos-
ing primary syphilis.
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Syphilis is caused by active infection with Trepo-
nema pallidum [1,2]. Laboratory diagnosis can be
performed by dark-field microscopy, serology
and PCR [3,4]. Dark-field microscopy can identify
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treponemes in primary lesions, but is relatively
insensitive. T. pallidum cannot be grown readily
in vitro; thus, serological testing is still the stand-
ard for laboratory diagnosis, but is relatively
insensitive for detecting the primary stage of
syphilis. Moreover, positive serology can also be
indicative of a past infection, and therefore does
not always prove that newly developed lesions
are caused by T. pallidum. In contrast, PCR assays
are highly sensitive and specific, and can be used
to detect T. pallidum in specimens from primary
lesions [3,5,6].
Existing diagnostic PCR assays for T. pallidum
use gel-based detection systems [3,5–7]. The
present study developed a new real-time PCR
assay for T. pallidum and evaluated it on two real-
time PCR platforms, the Rotor-Gene (Corbett
Research, Sydney, Australia) and the iCycler
(Bio-Rad, Veenendaal, The Netherlands) in two
laboratories. The PCR assay targeted the polA
gene, as the polymerase function is conserved
among strains of T. pallidum [8,9]. Beacon De-
signer v.3 (Premier Biosoft, Alton USA) and
GenBank sequence number AE000520 were used
to create a Taqman real-time PCR assay. The
forward primer sequence was 5¢-GGTAGAAGG-
GAGGGCTAGTA (nucleotides 116 777–116 796),
the reverse primer sequence was 5¢-CTAAG-
ATCTCTATTTTCTATAGGTATGG (nucleotides
116 854–116 881), and the Taqman probe
sequence was 5¢-ACACAGCACTCGTCTTCA-
ACTCC (nucleotides 116 825–116 847), labelled
5¢ with FAM and 3¢ with BHQ1. For both
platforms, the PCR mixture contained 300 nM
each primer, 340 nM probe, 5.5 mM MgCl2, and
200 lM dNTPs. For the iCycler, 0.02 U of Hot-
Start Taq Polymerase (Qiagen, Venlo, The Neth-
erlands) and 10 lL of sample (see below) were
used (total volume 50 lL); for the Rotor-Gene,
0.02 U of Taq polymerase (Roche Diagnostics,
Almere, The Netherlands) and 5 lL of sample
(total volume of 25 lL) were used. Amplification
comprised 50 cycles of 30 s at 95C, 30 s at 55C
and 30 s at 72C. The cut-off positive cycle
threshold (Ct) was <45 for the iCycler and <40
for the Rotor-Gene.
All genital ulcer swab samples came from
suspected syphilis patients attending the out-
patient sexually transmitted infections clinic in
Amsterdam. Two dry swab samples of genital
ulcer lesions were combined and eluted in 600 lL
of phosphate-buffered saline. For nucleic acid
isolation, 100 lL of eluate was added to 600 lL of
lysis buffer (bioMe´rieux, Boxtel, The Netherlands)
and incubated for 30 min at 65C. DNA was
precipitated with one volume of isopropanol.
After centrifugation at 14 000 g for 20 min, the
pellet was washed twice with 500 lL of ethanol
70% v ⁄v, air-dried and dissolved in 50 lL of
10 mM Tris-HCl, pH 8.0.
As a first step, dilution series of an Escherichia
coli plasmid carrying the polA gene were tested on
both real-time PCR platforms (Fig. 1). The Rotor-
Gene had consistently lower Ct values than the
iCycler, but both detected £1000 copies ⁄mL. The
assay was then tested with an analytical panel
consisting of 80 genital ulcer swab samples,
collected during 2002–2004 from 78 patients with
T. pallidum infection, as confirmed by nested PCR
[3], and 60 specificity controls containing water or
buffer (n = 10), nucleic acids isolated from non-
treponemal bacteria or moulds (n = 40), or nucleic
acids isolated from viruses (n = 10) [10]. The
sensitivity and specificity were 78 ⁄ 80 (97.5%) and
58 ⁄ 60 (96.7%), respectively, for the Rotor-Gene,
and 80 ⁄ 80 (100%) and 60 ⁄ 60 (100%), respectively,
for the iCycler. Four discordant results, two false-
positive and two false-negative, were obtained
with the Rotor-Gene platform. False-positive sam-
ples contained DNA from Candida albicans and
Burkholderia cepacia, but had high Ct values (35.8
and 38.4, respectively); both were negative fol-
lowing re-testing on the Rotor-Gene. The two
false-negative samples had high Ct values (38.4
and 40.7) in the iCycler, indicating a low DNA
target load, because both were originally positive
with nested PCR assays [3] (results not shown).
A second panel was collected prospectively,
between February and May 2005, and contained
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Fig. 1. Cut-off positive cycle threshold (Ct) values for a
dilution series of a plasmid containing the polA gene of
Treponema pallidum.
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112 samples from patients with suspected syph-
ilis. Routine, validated in-house nested PCR was
also performed [3]. For real-time PCR testing,
both participating laboratories received a 20-lL
aliquot, and added phocine herpes virus type 1
cDNA as an internal inhibition control [11].
Multiplexing with phocine herpes virus type 1
did not affect sensitivity and none of the samples
was inhibited.
The final result for each patient was determined
by combining the results from both real-time PCR
assays and the nested PCR assay, and was defined
as ‘negative’ or ‘positive’ when all three PCR
results were concordant. In the case of discrepant
results, dark-fieldmicroscopy and serology (T. pal-
lidum particle antigen, fluorescent treponemal
antibody and Venereal Disease Research Laborat-
ory (VDRL) tests) were included to determine the
most likely true status of the sample. Sensitivity,
specificity, positive predictive value and negative
predictive value were calculated for both real-time
PCR platforms (Table 1). Fourteen samples were
positive in all PCR assays and 94 were negative. Of
four discrepant samples, two were considered
negative and two positive (Table 1). One positive
samplewas negative by nestedPCR, and theRotor-
Gene yielded one false-positive result. The other
twodiscordant samples (one false-positive and one
false-negative) with the iCycler were reporting
errors. The overall results for each test format with
the prospective panel are also shown in Table 1.
In conclusion, the real-time PCR assay for
T. pallidum described in this study was at least
as sensitive and specific as the established nested
PCR assay. The assay worked well on both
platforms and required minimal optimisation.
The Rotor-Gene gave Ct values lower than the
iCycler, perhaps because of differences in the way
the software handled the curves. The iCycler uses
a heat block, whereas tubes in the Rotor-Gene are
air-heated and cooled in a centrifuge. Thus, Ct
values should be interpreted according to the
platform, and quantification should only be
attempted following direct comparison with
known standards. The analytical panel samples
giving false-negative results in the Rotor-Gene
probably had a low DNA load. The false-positive
samples in both panels occurred when positioned
after a high-load positive sample, so carry-over
contamination may explain these discrepancies.
The assay can be completed within 2 h, and the
total time from receiving the sample to reporting
results is less than one working day. The assay is
therefore highly suitable for implementation in
routine diagnostic laboratories.
R E F E R E N C E S
1. Htun Y, Morse SA, Dangor Y et al. Comparison of clinic-
ally directed, disease specific, and syndromic protocols for
the management of genital ulcer disease in Lesotho. Sex
Transm Infect 1998; 74 (suppl 1): S23–S28.
2. Singh AE, Romanowski B. Syphilis: review with emphasis
on clinical, epidemiologic, and some biologic features. Clin
Microbiol Rev 1999; 12: 187–209.
3. Bruisten SM, Cairo I, Fennema H et al. Diagnosing genital
ulcer disease in a clinic for sexually transmitted diseases in
Amsterdam, The Netherlands. J Clin Microbiol 2001; 39:
601–605.
4. Larsen SA, Steiner BM, Rudolph AH. Laboratory diagno-
sis and interpretation of tests for syphilis. Clin Microbiol
Rev 1995; 8: 1–21.
Table 1. Results obtained with 112 genital ulcer swabs analysed with nested PCR and two real-time PCR assays
Discrepant samples
Nested PCR-positive (n = 15) Nested PCR-negative (n = 97)
iCycler positive iCycler negative iCycler positive iCycler negative
Rotor-Gene positive 14 1a 1a 1b
Rotor-Gene negative 0 0 1b 94
Final results
Nested PCR Rotor-Gene iCycler
No. % No. % No. %
Sensitivity 15 ⁄ 16 93.8 16 ⁄ 16 100 15 ⁄ 16 93.8
Specificity 96 ⁄ 96 100 95 ⁄ 96 99 96 ⁄ 96 100
PPV 15 ⁄ 15 100 16 ⁄ 17 94.1 15 ⁄ 16 93.8
NPV 96 ⁄ 97 99 95 ⁄ 95 100 95 ⁄ 96 99
aTrue-positive based on dark-field microscopy and serology.
bTrue-negative based on dark-field microscopy and serology.
PPV, positive-predictive value; NPV, negative predictive value.
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A B S T R A C T
Carbapenem-resistant Acinetobacter baumannii iso-
lates producing carbapenem-hydrolysing oxacil-
linases are emerging worldwide. These enzymes
are divided into four phylogenetic subgroups:
OXA-23-like, OXA-51-like, OXA-24-like and
OXA-58-like. A PCR-based approach linked to
pyrosequencing analysis was developed to iden-
tify the genes for these b-lactamases. Carbape-
nem-hydrolysing oxacillinases were rapidly and
unambiguously identified in a collection of carb-
apenem-resistant clinical isolates of A. baumannii
and Acinetobacter junii. Pyrosequencing may pro-
vide a rapid tool for identification of OXA
variants, thus avoiding delays inherent in clas-
sical sequencing methods.
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Carbapenems are the drugs of choice for treating
nosocomial infections caused by multidrug-resist-
ant Acinetobacter baumannii [1,2]. However, their
efficacy is being increasingly compromised as
carbapenem-resistant isolates are becoming wide-
spread in certain regions of the world [3–6]. A
variety of molecular resistance mechanisms to
carbapenems have been reported in A. baumannii,
including rare mutations in genes coding for
penicillin-binding proteins and alterations in
outer-membrane permeability, but the most com-
mon resistance mechanism involves the acquisi-
tion of carbapenem-hydrolysing b-lactamases
belonging to Ambler class B (metallo-enzymes)
and, predominantly, Ambler class D (oxacillinas-
es) [2,7,8].
The carbapenem-hydrolysing class D b-lacta-
mases (CHDLs) of Acinetobacter spp. are divided
into four phylogenetic subgroups: OXA-23-like,
OXA-24-like, OXA-51-like and OXA-58-like [8]. It
has been suggested that enzymes belonging to the
OXA-51-like subgroup may be intrinsic to A. bau-
mannii [9], based on their chromosomal location
and their ubiquitous distribution among A. bau-
mannii strains. Outbreaks of CHDL-producing
A. baumannii strains have been increasingly repor-
ted, involving, e.g., OXA-24 in Spain [7] and
OXA-40 in Spain and Portugal [10,11]; OXA-23 in
Brazil, French Polynesia, Spain, Korea and the UK
[12,13]; and OXA-58 worldwide [6,14,15]. The aim
of the present study was to develop a PCR-based
method for the detection of acquired blaOXA
genes, to be used in combination with pyro-
Corresponding author and reprint requests: T. Naas, Service
de Bacte´riologie-Virologie, Hoˆpital de Biceˆtre, 78 rue du
Ge´ne´ral Leclerc, 94275 K.-Biceˆtre, France
E-mail: thierry.naas@bct.ap-hop-paris.fr
1236 Clinical Microbiology and Infection, Volume 12 Number 12, December 2006
 2006 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 12, 1221–1240
